Association of sterol regulatory element-binding protein-1c gene polymorphism with type 2 diabetes mellitus, insulin resistance and blood lipid levels in Chinese population

Diabetes Research and Clinical Practice

Volumn 82, Issue 1, 2008, Pages 42-47

  Liu, Ju xiang ^a,c   Liu, Jing ^b   Li, Pei qiang ^a   Xie, Xiao dong ^a   Guo, Qian ^b   Tian, Li min ^b   Ma, Xiao qin ^b   Zhang, Ji ping ^a   Liu, Jia ^a   Gao, Jing yuan ^a  

^a LANZHOU UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

^c Gansu Cancer Hospital   (China)

Author keywords

Insulin resistance; Lipids; Polymorphism; Sterol regulatory element binding protein 1c; Type 2 diabetes

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 52949085061     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.06.017     Document Type: Article

References (27)

1. Weyer C., Bogardus C., Mott D.M., and Pratley R.E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes. J. Clin. Invest. 104 (1999) 787-794
2. Sinha R., Dufour S., Petersen K.F., LeBon V., Enoksson S., Ma Y.Z., et al. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51 (2002) 1022-1027
3. Lupi R., Del Guerra S., Fierabracci V., Marselli L., Novelli M., Patanè G., et al. Diabetes: lipotoxicity in human pancreatic islets and the protective effect of metformin. Diabetes 51 Suppl. 1 (2002) S117-S134
4. Lam T.K., van de Werve G., and Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E281-E290
5. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 (2002) 1125-1131
6. Foufelle F., and Ferré P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem. J. 366 (2002) 377-391
7. Hua X., Wu J., Goldstein J.L., Brown M.S., and Hobbs H.H. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics 25 (1995) 667-673
8. Miserez A.R., Cao G., Probst L.C., and Hobbs H.H. Structure of the human gene encoding sterol regulatory element binding protein 2 (SREBF2). Genomics 40 (1997) 31-40
9. Demenais F., Kanninen T., Lindgren C.M., Wiltshire S., Gaget S., Dandrieux C., et al. A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes. Hum. Mol. Genet. 12 (2003) 1865-1873
10. Laudes M., Barroso I., Luan J., Soos M.A., Yeo G., Meirhaeghe A., et al. Genetic variants in human sterol regulatory element binding protein-1c in syndromes of severe insulin resistance and type 2 diabetes. Diabetes 53 (2004) 842-846
11. Eberlé D., Clément K., Meyre D., Sahbatou M., Vaxillaire M., Le Gall A., et al. SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts. Diabetes 53 (2004) 2153-2157
12. Felder T.K., Oberkofler H., Weitgasser R., Mackevics V., Krempler F., Paulweber B., and Patsch W. The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian population. Int. J. Obes. (Lond.) 31 7 (2007) 1099-1103
13. Harding A.H., Loos R.J., Luan J., O'Rahilly S., Wareham N.J., and Barroso I. Polymorphisms in the gene encoding sterol regulatory element-binding factor-1c are associated with type 2 diabetes. Diabetologia 49 (2006) 2642-2648
14. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15 (2005) 97-98
15. Cazzola M., and Skoda R.C. Translational pathophysiology: a novel molecular mechanism of human disease. Blood 95 (2000) 3280-3288
16. The International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
17. Laaksonen R., Thelen K.M., Päivä H., Matinheikki J., Vesalainen R., Janatuinen T., et al. Genetic variant of the SREBF-1 gene is significantly related to cholesterol synthesis in man. Atherosclerosis 185 (2006) 206-209
18. Berthold H.K., Laaksonen R., Lehtimäki T., Gylling H., Krone W., and Gouni-Berthold I. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment. Clin. Endocrinol. Diabetes 116 (2008) 262-267
19. Heemers H., Vanderhoydonc F., Roskams T., Shechter I., Heyns W., Verhoeven G., and Swinnen J.V. Androgens stimulate coordinated lipogenic gene expression in normal target tissues in vivo. Mol. Cell. Endocrinol. 205 (2003) 21-31
20. Ide T., Shimano H., Yahagi N., Matsuzaka T., Nakakuki M., Yamamoto T., et al. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat. Cell Biol. 6 (2004) 351-357
21. Wang H., Maechler P., Antinozzi P.A., Herrero L., Hagenfeldt-Johansson K.A., Bjorklund A., and Wollheim C.B. The transcription factor SREBP-1c is instrumental in the development of beta-cell dysfunction. J. Biol. Chem. 278 (2003) 16622-16629
22. Takahashi A., Motomura K., Kato T., Yoshikawa T., Nakagawa Y., Yahagi N., et al. Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta-cells. Diabetes 54 (2005) 492-499
23. Sewter C., Berger D., Considine R.V., Medina G., Rochford J., Ciaraldi T., et al. Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor. Diabetes 51 (2002) 1035-1041
24. Foretz M., Pacot C., Dugail I., Lemarchand P., Guichard C., Le Lièpvre X., et al. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol. Cell Biol. 19 (1999) 3760-3768
25. Kim J.B., Sarraf P., Wright M., Yao K.M., Mueller E., Solanes G., et al. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J. Clin. Invest. 101 (1998) 1-9
26. Le Lay S., Lefrère I., Trautwein C., Dugail I., and Krief S. Insulin and sterol-regulatory element-binding protein-1c (SREBP-1c) regulation of gene expression in 3T3-L1 adipocytes. Identification of CCAAT/enhancer-binding protein beta as an SREBP-1c target. J. Biol. Chem. 277 (2002) 35625-35634
27. Ferré P., and Foufelle F. SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm. Res. 68 2 (2007) 72-82